key: cord-0819710-ld9agd1w
authors: Wang, Kevin C.; Xiao, Ryan; Cheung, Zoe B.; Barbera, Joseph P.; Forsh, David A.
title: Early mortality after hip fracture surgery in COVID-19 patients: A systematic review and meta-analysis
date: 2020-11-17
journal: J Orthop
DOI: 10.1016/j.jor.2020.11.012
sha: 6d0cbc7938851fa3456df598e7f163e887a9a1ad
doc_id: 819710
cord_uid: ld9agd1w

OBJECTIVE: The aim of this systematic review and meta-analysis was to assess the risk of early mortality in hip fracture patients with COVID-19 infection who undergo surgical intervention. DATA SOURCES: MEDLINE (PubMed) and CINAHL (Cumulative Index to Nursing and Allied Health Literature) databases. STUDY SELECTION: Studies were included in the systematic review if they reported postoperative mortality in patients with COVID-19 infection who underwent operative intervention for hip fracture. From this selection of studies, only investigations that reported postoperative mortality in a COVID-positive and a non-COVID group were included in the meta-analysis. DATA EXTRACTION: Data regarding patient demographics, age, and sex were recorded. Additional data that was extracted included study location, data collection period, length of follow-up, COVID testing methodology, COVID testing results, and number of patients who underwent operative versus nonoperative management. The primary outcome of interest was postoperative mortality. DATA SYNTHESIS: Random effects meta-analyses were performed to assess the pooled relative risk of postoperative mortality according to COVID status. Odds ratios and 95% confidence intervals (CI) were calculated. CONCLUSIONS: The overall pooled mortality rate in the early postoperative period for hip fracture patients with concomitant COVID-19 infection was 32.6%. The relative risk for postoperative mortality in COVID-positive patients compared to non-COVID patients was 5.66 (95% CI 4.01–7.98; p < 0.001). The currently available literature demonstrates that COVID-19 infection represents a substantial risk factor for early postoperative mortality in the already susceptible hip fracture population. Further investigations will be needed to assess longer-term morbidity and mortality in this patient population. LEVEL OF EVIDENCE: Therapeutic Level IV.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) -also known as 2019 30 novel coronavirus or COVID-19 -first emerged on December 31, 2019 in China, and has since 31 rapidly spread to become a world-wide pandemic. The impact of this pandemic has been 32 widespread, but healthcare systems have been uniquely affected. In the field of orthopaedic 33 surgery, there has been a significant decline in the volume of surgical cases [1] . In some . Because of its significant potential to adversely affect outcomes, COVID-19 status is an 52 important variable to consider in developing treatment algorithms for hip fracture patients in the 53 setting of the ongoing pandemic [15] . The objective of this study was to perform a systematic 54 review and meta-analysis of the current literature reporting on the early outcomes of hip fracture 55 patients with COVID-19 infection who underwent surgical intervention. The meta-analysis 56 aimed to assess the risk of mortality in this patient population compared to non-COVID hip 57 fracture patients. We hypothesized that there would be a significantly elevated rate of early 58 mortality in COVID-positive (COVID+) patients who underwent hip fracture surgery. (Table 1) . 125 There were 2 studies from Asia (1 from China and 1 from Iran), 3 studies from the United States 126 (all from New York City), and 11 studies from Europe (7 from the United Kingdom, 2 from 127 Spain, and 2 from Italy).

Demographics. Table 1 

Impact of COVID-19 on orthopaedic and trauma service: an 270 epidemiological study